These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28923789)

  • 1. Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.
    Markey KA; Ottridge R; Mitchell JL; Rick C; Woolley R; Ives N; Nightingale P; Sinclair AJ
    JMIR Res Protoc; 2017 Sep; 6(9):e181. PubMed ID: 28923789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial.
    Markey K; Mitchell J; Botfield H; Ottridge RS; Matthews T; Krishnan A; Woolley R; Westgate C; Yiangou A; Alimajstorovic Z; Shah P; Rick C; Ives N; Taylor AE; Gilligan LC; Jenkinson C; Arlt W; Scotton W; Fairclough RJ; Singhal R; Stewart PM; Tomlinson JW; Lavery GG; Mollan SP; Sinclair AJ
    Brain Commun; 2020; 2(1):fcz050. PubMed ID: 32954315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension.
    Hardy RS; Botfield H; Markey K; Mitchell JL; Alimajstorovic Z; Westgate CSJ; Sagmeister M; Fairclough RJ; Ottridge RS; Yiangou A; Storbeck KH; Taylor AE; Gilligan LC; Arlt W; Stewart PM; Tomlinson JW; Mollan SP; Lavery GG; Sinclair AJ
    J Clin Endocrinol Metab; 2021 Jan; 106(1):174-187. PubMed ID: 33098644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.
    Ajjan RA; Hensor EMA; Del Galdo F; Shams K; Abbas A; Fairclough RJ; Webber L; Pegg L; Freeman A; Taylor AE; Arlt W; Morgan AW; Tahrani AA; Stewart PM; Russell DA; Tiganescu A
    Eur J Endocrinol; 2022 Feb; 186(4):441-455. PubMed ID: 35113805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation?
    Sinclair AJ; Walker EA; Burdon MA; van Beek AP; Kema IP; Hughes BA; Murray PI; Nightingale PG; Stewart PM; Rauz S; Tomlinson JW
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5348-56. PubMed ID: 20826586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental drugs for the treatment of idiopathic intracranial hypertension (IIH): shedding light on phase I and II trials.
    Khatkar P; Hubbard JC; Hill L; Sinclair AJ; Mollan SP
    Expert Opin Investig Drugs; 2023; 32(12):1123-1131. PubMed ID: 38006580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol.
    Ottridge R; Mollan SP; Botfield H; Frew E; Ives NJ; Matthews T; Mitchell J; Rick C; Singhal R; Woolley R; Sinclair AJ
    BMJ Open; 2017 Sep; 7(9):e017426. PubMed ID: 28963303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 11β-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study.
    Yadav Y; Dunagan K; Khot R; Venkatesh SK; Port J; Galderisi A; Cobelli C; Wegner C; Basu A; Carter R; Basu R
    Diabetes Obes Metab; 2022 May; 24(5):881-890. PubMed ID: 35014156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache.
    Grech O; Seneviratne SY; Alimajstorovic Z; Yiangou A; Mitchell JL; Smith TB; Mollan SP; Lavery GG; Ludwig C; Sinclair AJ
    Neurology; 2022 Oct; 99(16):e1702-e1714. PubMed ID: 36240084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.
    Othonos N; Pofi R; Arvaniti A; White S; Bonaventura I; Nikolaou N; Moolla A; Marjot T; Stimson RH; van Beek AP; van Faassen M; Isidori AM; Bateman E; Sadler R; Karpe F; Stewart PM; Webster C; Duffy J; Eastell R; Gossiel F; Cornfield T; Hodson L; Jane Escott K; Whittaker A; Kirik U; Coleman RL; Scott CAB; Milton JE; Agbaje O; Holman RR; Tomlinson JW
    Nat Commun; 2023 Feb; 14(1):1025. PubMed ID: 36823106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
    ; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
    JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases.
    Markey KA; Uldall M; Botfield H; Cato LD; Miah MA; Hassan-Smith G; Jensen RH; Gonzalez AM; Sinclair AJ
    J Pain Res; 2016; 9():223-32. PubMed ID: 27186074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial.
    Mollan SP; Mitchell JL; Ottridge RS; Aguiar M; Yiangou A; Alimajstorovic Z; Cartwright DM; Grech O; Lavery GG; Westgate CSJ; Vijay V; Scotton W; Wakerley BR; Matthews TD; Ansons A; Hickman SJ; Benzimra J; Rick C; Singhal R; Tahrani AA; Brock K; Frew E; Sinclair AJ
    JAMA Neurol; 2021 Jun; 78(6):678-686. PubMed ID: 33900360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging themes in idiopathic intracranial hypertension.
    Grech O; Mollan SP; Wakerley BR; Alimajstorovic Z; Lavery GG; Sinclair AJ
    J Neurol; 2020 Dec; 267(12):3776-3784. PubMed ID: 32700012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic intracranial hypertension VISION (venous intervention versus shunting in IIH for optic nerve disc swelling) trial: patient perspective questionnaire.
    Chandran A; Pulhorn H; McMahon C
    Br J Neurosurg; 2019 Feb; 33(1):71-75. PubMed ID: 28934871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema.
    Huang-Link Y; Eleftheriou A; Yang G; Johansson JM; Apostolou A; Link H; Jin YP
    Eur J Neurol; 2019 May; 26(5):808-e57. PubMed ID: 30586220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: A narrative review.
    Mollan SP; Grech O; Sinclair AJ
    Headache; 2021 Jun; 61(6):808-816. PubMed ID: 34106464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension.
    Mollan SP; Wakerley BR; Alimajstorovic Z; Mitchell J; Ottridge R; Yiangou A; Thaller M; Gupta A; Grech O; Lavery G; Brock K; Sinclair AJ
    J Headache Pain; 2021 Oct; 22(1):118. PubMed ID: 34620087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between idiopathic intracranial hypertension and obesity.
    Hannerz J; Ericson K
    Headache; 2009 Feb; 49(2):178-84. PubMed ID: 19222591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS).
    Yamaguchi N; Misawa S; Sato Y; Nagashima K; Katayama K; Sekiguchi Y; Iwai Y; Amino H; Suichi T; Yokota T; Nishida Y; Kohara N; Hirata K; Nishiyama K; Yabe I; Kaida KI; Suzuki N; Nodera H; Tsuji S; Koike H; Kira JI; Hanaoka H; Kusunoki S; Kuwabara S;
    JMIR Res Protoc; 2016 Nov; 5(4):e210. PubMed ID: 27821382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.